New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.
BigCountryHomepage on MSN
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...
When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders—and reduce the tragic outcomes they cause, a large new study ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) announced on July 29 it is taking action to restrict 7-OH opioid products threatening ...
For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 ...
Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) ...
Alabama has been through a lot in recent years. We are still recovering from the covid pandemic and families in our state have faced excessive costs from groceries to prescription drugs. We have ...
The FDA is taking action to restrict 7-OH opioid products, a concentrated byproduct of the kratom plant. Kratom, a tropical tree native to Southeast Asia, can cause stimulant effects in low doses and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results